# MIS-C Comparative Effectiveness Study

> **NCT04898231** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 73 (actual)

## Conditions studied

- Multisystem Inflammatory Syndrome-Children

## Interventions

- **DRUG:** Infliximab
- **DRUG:** Anakinra
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT04898231
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-22
- **Primary completion:** 2023-12-22
- **Final completion:** 2024-04-25
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2025-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04898231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04898231, "MIS-C Comparative Effectiveness Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04898231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*